06/04/2026
Cell and gene therapy has never had more momentum. Approved therapies continue to grow. Manufacturing capabilities are expanding. Investment is returning to key areas of the field. Yet many of the industry's biggest questions remain unanswered.
- How do we scale sustainably?
- How do we improve patient access?
- How do we move from scientific success to commercial success?
These are exactly the questions we'll explore with Dr. Phil Vanek, PhD, Chief Commercialization Officer at ISCT, during our next Bridging the Gap webinar. Join us for a forward-looking discussion on the future of the industry and the steps needed to translate innovation into broader patient impact.
Register: https://hubs.ly/Q04jPJZM0